SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000886163-20-000097
Filing Date
2020-08-07
Accepted
2020-08-07 17:27:39
Documents
57
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q lgnd-20200630.htm   iXBRL 10-Q 1972637
2 EX-31.1 lgnd63020exhibit311.htm EX-31.1 20489
3 EX-31.2 lgnd63020exhibit312.htm EX-31.2 20831
4 EX-32.1 lgnd63020exhibit321.htm EX-32.1 15186
10 lgnd-20200630_g1.jpg GRAPHIC 11735
  Complete submission text file 0000886163-20-000097.txt   8638113

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lgnd-20200630.xsd EX-101.SCH 42433
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT lgnd-20200630_cal.xml EX-101.CAL 103685
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT lgnd-20200630_def.xml EX-101.DEF 246053
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lgnd-20200630_lab.xml EX-101.LAB 622966
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lgnd-20200630_pre.xml EX-101.PRE 383397
11 EXTRACTED XBRL INSTANCE DOCUMENT lgnd-20200630_htm.xml XML 1798140
Mailing Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121
Business Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121 858-550-7500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

IRS No.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33093 | Film No.: 201085601
SIC: 2834 Pharmaceutical Preparations